[1] |
Boniel S, Szymańska K, Smigiel R, et al. Kabuki Syndrome-Clinical Review with Molecular Aspects[J]. Genes(Basel), 2021, 12(4):468. doi: 10.3390/genes12040468.
|
[2] |
Kawai T, Iwasaki Y, Ogata-Kawata H, et al. Identification of a KDM6A somatic mutation responsible for Kabuki syndrome by excluding a conflicting KMT2D germline variant through episignature analysis[J]. Eur J Med Genet, 2023, 66(8):104806. doi: 10.1016/j.ejmg.2023.104806.
|
[3] |
Shpargel KB, Quickstad G. SETting up the genome: KMT2D and KDM6A genomic function in the Kabuki syndrome craniofacial developmental disorder[J]. Birth Defects Res, 2023, 115(20):1885-1898. doi: 10.1002/bdr2.2253.
pmid: 37800171
|
[4] |
Barry KK, Tsaparlis M, Hoffman D, et al. From Genotype to Phenotype-A Review of Kabuki Syndrome[J]. Genes(Basel), 2022, 13(10):1761. doi: 10.3390/genes13101761.
|
[5] |
王红梅, 王晓慧, 吴沪生, 等. Kabuki综合征临床和实验室特点及基因诊断[J]. 中华儿科杂志, 2018, 56(11):846-849. doi: 10.3760/ cma.j.issn.0578-1310.2018.11.010.
|
[6] |
Froimchuk E, Jang Y, Ge K. Histone H3 lysine 4 methyltransferase KMT2D[J]. Gene, 2017, 627:337-342. doi: 10.1016/j.gene.2017.06.056.
pmid: 28669924
|
[7] |
Luperchio TR, Applegate CD, Bodamer O, et al. Haploinsufficiency of KMT2D is sufficient to cause Kabuki syndrome and is compatible with life[J]. Mol Genet Genomic Med, 2020, 8(2):e1072. doi: 10.1002/mgg3.1072.
|
[8] |
Jefri M, Zhang X, Stumpf PS, et al. Kabuki syndrome stem cell models reveal locus specificity of histone methyltransferase 2D (KMT2D/MLL4)[J]. Hum Mol Genet, 2022, 31(21):3715-3728. doi: 10.1093/hmg/ddac121.
pmid: 35640156
|
[9] |
Goodman SJ, Luperchio TR, Ellegood J, et al. Peripheral blood DNA methylation and neuroanatomical responses to HDACi treatment that rescues neurological deficits in a Kabuki syndrome mouse model[J]. Clin Epigenetics, 2023, 15(1):172. doi: 10.1186/s13148-023-01582-x.
pmid: 37884963
|
[10] |
So PL, Luk HM, Yu K, et al. Clinical and molecular characterization study of Chinese Kabuki syndrome in Hong Kong[J]. Am J Med Genet A, 2021, 185(3):675-686. doi: 10.1002/ajmg.a.62003.
|
[11] |
Schwenty-Lara J, Nehl D, Borchers A. The histone methyltransferase KMT2D, mutated in Kabuki syndrome patients, is required for neural crest cell formation and migration[J]. Hum Mol Genet, 2020, 29(2):305-319. doi: 10.1093/hmg/ddz284.
pmid: 31813957
|
[12] |
Digilio MC, Gnazzo M, Lepri F, et al. Congenital heart defects in molecularly proven Kabuki syndrome patients[J]. Am J Med Genet A, 2017, 173(11):2912-2922. doi: 10.1002/ajmg.a.38417.
pmid: 28884922
|
[13] |
Maines E, Maiorana A, Leonardi L, et al. A narrative review on pathogenetic mechanisms of hyperinsulinemic hypoglycemia in Kabuki syndrome[J]. Endocr Regul, 2023, 57(1):128-137. doi: 10.2478/enr-2023-0016.
pmid: 37285460
|
[14] |
Guo W, Zhao Y, Li S, et al. Hypoglycemia and Dandy-Walker variant in a Kabuki syndrome patient: a case report[J]. BMC Med Genet, 2020, 21(1):193. doi: 10.1186/s12881-020-01117-8.
pmid: 33008324
|
[15] |
Miyake N, Koshimizu E, Okamoto N, et al. MLL2 and KDM6A mutations in patients with Kabuki syndrome[J]. Am J Med Genet A, 2013, 161A(9):2234-2243. doi: 10.1002/ajmg.a.36072.
pmid: 23913813
|
[16] |
Niikawa N, Kuroki Y, Kajii T, et al. Kabuki make-up (Niikawa-Kuroki) syndrome: a study of 62 patients[J]. Am J Med Genet, 1988, 31(3):565-589. doi: 10.1002/ajmg.1320310312.
|
[17] |
Wang YR, Xu NX, Wang J, et al. Kabuki syndrome: review of the clinical features, diagnosis and epigenetic mechanisms[J]. World J Pediatr, 2019, 15(6):528-535. doi: 10.1007/s12519-019-00309-4.
|